• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子分化标志物的表达与肝内胆管癌的组织学分化程度不相关。

Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.

作者信息

Demarez Céline, Hubert Catherine, Sempoux Christine, Lemaigre Frédéric P

机构信息

de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 75, B-1200 Brussels, Belgium.

Division of Hepato-Biliary and Pancreatic Surgery, Department of Abdominal Surgery and Transplantation, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium.

出版信息

PLoS One. 2016 Jun 9;11(6):e0157140. doi: 10.1371/journal.pone.0157140. eCollection 2016.

DOI:10.1371/journal.pone.0157140
PMID:27280413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4900546/
Abstract

The differentiation status of tumor cells, defined by histomorphological criteria, is a prognostic factor for survival of patients affected with intrahepatic cholangiocarcinoma (ICC). To strengthen the value of morphological differentiation criteria, we wished to correlate histopathological differentiation grade with expression of molecular biliary differentiation markers and of microRNAs previously shown to be dysregulated in ICC. We analysed a series of tumors that were histologically classified as well, moderately or poorly differentiated, and investigated the expression of cytokeratin 7, 19 and 903 (CK7, CK19, CK903), SRY-related HMG box transcription factors 4 and 9 (SOX4, SOX9), osteopontin (OPN), Hepatocyte Nuclear Factor-1 beta (HNF1β), Yes-associated protein (YAP), Epithelial cell adhesion molecule (EPCAM), Mucin 1 (MUC1) and N-cadherin (NCAD) by qRT-PCR and immunostaining, and of miR-31, miR-135b, miR-132, miR-200c, miR-221 and miR-222. Unexpectedly, except for subcellular location of SOX9 and OPN, no correlation was found between the expression levels of these molecular markers and histopathological differentiation grade. Therefore, our data point toward necessary caution when investigating the evolution and prognosis of ICC on the basis of cell differentiation criteria.

摘要

根据组织形态学标准定义的肿瘤细胞分化状态,是肝内胆管癌(ICC)患者生存的一个预后因素。为了强化形态学分化标准的价值,我们希望将组织病理学分化程度与分子胆管分化标志物以及先前已证实在ICC中失调的微小RNA的表达相关联。我们分析了一系列组织学上分类为高分化、中分化或低分化的肿瘤,并通过定量逆转录聚合酶链反应(qRT-PCR)和免疫染色研究了细胞角蛋白7、19和903(CK7、CK19、CK903)、SRY相关高迁移率族盒转录因子4和9(SOX4、SOX9)、骨桥蛋白(OPN)、肝细胞核因子-1β(HNF1β)、Yes相关蛋白(YAP)、上皮细胞粘附分子(EPCAM)、粘蛋白1(MUC1)和N-钙粘蛋白(NCAD)的表达,以及miR-31、miR-135b、miR-132、miR-200c、miR-221和miR-222的表达。出乎意料的是,除了SOX9和OPN的亚细胞定位外,这些分子标志物的表达水平与组织病理学分化程度之间未发现相关性。因此,我们的数据表明,在基于细胞分化标准研究ICC的进展和预后时需要谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/78463a721b27/pone.0157140.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/74748e76ab15/pone.0157140.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/1ee0008c0b2e/pone.0157140.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/ac6758deab04/pone.0157140.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/3a12dc17efb8/pone.0157140.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/78463a721b27/pone.0157140.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/74748e76ab15/pone.0157140.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/1ee0008c0b2e/pone.0157140.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/ac6758deab04/pone.0157140.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/3a12dc17efb8/pone.0157140.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da5f/4900546/78463a721b27/pone.0157140.g005.jpg

相似文献

1
Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.分子分化标志物的表达与肝内胆管癌的组织学分化程度不相关。
PLoS One. 2016 Jun 9;11(6):e0157140. doi: 10.1371/journal.pone.0157140. eCollection 2016.
2
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.EYA4基因作为一种预后标志物发挥作用,并抑制肝内胆管癌的生长。
Chin J Cancer. 2016 Jul 28;35(1):70. doi: 10.1186/s40880-016-0133-z.
3
High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.高迁移率族蛋白盒1在肝内胆管癌中的表达与淋巴结转移
World J Gastroenterol. 2015 Mar 21;21(11):3256-65. doi: 10.3748/wjg.v21.i11.3256.
4
Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.Fascin过表达与人类肝内胆管癌的发生及预后相关:免疫组织化学和分子分析
Hum Pathol. 2009 Feb;40(2):174-80. doi: 10.1016/j.humpath.2008.06.029. Epub 2008 Oct 5.
5
CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.细胞角蛋白7/细胞角蛋白19指数:肝内胆管癌术后患者的一个潜在预后因素。
J Surg Oncol. 2018 Jun;117(7):1531-1539. doi: 10.1002/jso.25027. Epub 2018 Mar 7.
6
[Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].[黏蛋白糖蛋白和细胞角蛋白在肝内胆管癌中的表达]
Zhonghua Bing Li Xue Za Zhi. 2008 Nov;37(11):749-53.
7
Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.下调的血液循环miR-150-5p作为胆管癌新型肿瘤标志物的分析
Tumour Biol. 2016 Nov;37(11):15019-15029. doi: 10.1007/s13277-016-5313-6. Epub 2016 Sep 22.
8
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.多基因突变异质性揭示胆管癌:手术切除患者的临床及预后相关性
Ann Surg Oncol. 2016 May;23(5):1699-707. doi: 10.1245/s10434-015-5046-6. Epub 2015 Dec 30.
9
Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.Sox9在致癌过程中的表达及其在肝内胆管癌中的临床意义。
Dig Liver Dis. 2015 Dec;47(12):1067-75. doi: 10.1016/j.dld.2015.08.003. Epub 2015 Aug 18.
10
Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.水通道蛋白-1在肝内胆管癌中的下调与肿瘤进展及黏蛋白表达有关。
Hum Pathol. 2007 Dec;38(12):1819-25. doi: 10.1016/j.humpath.2007.04.016. Epub 2007 Sep 14.

引用本文的文献

1
IL-13 as Target to Reduce Cholestasis and Dysbiosis in Knockout Mice.IL-13 作为靶点减少敲除小鼠的胆汁淤积和肠道菌群失调。
Cells. 2020 Aug 24;9(9):1949. doi: 10.3390/cells9091949.
2
Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma.每肿瘤体积的循环骨桥蛋白作为可切除性肝内胆管癌的预后生物标志物。
Hepatobiliary Surg Nutr. 2019 Dec;8(6):582-596. doi: 10.21037/hbsn.2019.03.14.
3
Notch Inhibition Promotes Differentiation of Liver Progenitor Cells into Hepatocytes via Repression in Zebrafish.

本文引用的文献

1
Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.胆管癌发病机制中的分子标志物:早期检测及选择合适治疗方法的潜力
Gastroenterology Res. 2009 Jun;2(3):132-140. doi: 10.4021/gr2009.06.1299. Epub 2009 May 20.
2
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.利用人类多能干细胞和患者来源的肿瘤类器官进行胰腺导管癌建模和药物筛选。
Nat Med. 2015 Nov;21(11):1364-71. doi: 10.1038/nm.3973. Epub 2015 Oct 26.
3
Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
Notch抑制通过在斑马鱼中的抑制作用促进肝祖细胞向肝细胞分化。
Stem Cells Int. 2019 Mar 12;2019:8451282. doi: 10.1155/2019/8451282. eCollection 2019.
4
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.胆管癌中失调的微小RNA:功能靶点与潜在生物标志物
Biomed Res Int. 2016;2016:4805270. doi: 10.1155/2016/4805270. Epub 2016 Nov 9.
Sox9在致癌过程中的表达及其在肝内胆管癌中的临床意义。
Dig Liver Dis. 2015 Dec;47(12):1067-75. doi: 10.1016/j.dld.2015.08.003. Epub 2015 Aug 18.
4
Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma.肝细胞细胞核因子-1β过表达预示预后不良与肝细胞癌患者的胆管表型相关。
Sci Rep. 2015 Aug 27;5:13319. doi: 10.1038/srep13319.
5
The risk factors and diagnosis of cholangiocarcinoma.胆管癌的危险因素与诊断
Hepatol Int. 2013 Jun;7(2):377-93. doi: 10.1007/s12072-012-9407-y. Epub 2012 Nov 10.
6
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors.YAP 通过 TEAD 转录因子促进人胆管癌的增殖、化疗耐药和血管生成。
Hepatology. 2015 Nov;62(5):1497-510. doi: 10.1002/hep.27992. Epub 2015 Aug 25.
7
Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts.转录因子SOX4和SOX9协同控制胆管的发育。
Dev Biol. 2015 Aug 15;404(2):136-48. doi: 10.1016/j.ydbio.2015.05.012. Epub 2015 May 29.
8
YAP is a critical oncogene in human cholangiocarcinoma.YAP是人类胆管癌中的一种关键致癌基因。
Oncotarget. 2015 Jul 10;6(19):17206-20. doi: 10.18632/oncotarget.4043.
9
A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.与华支睾吸虫诱导的胆管癌组织及血浆相关的微小RNA谱
BMC Cancer. 2015 Apr 23;15:309. doi: 10.1186/s12885-015-1270-5.
10
Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.与肝内胆管癌(ICC)患者预后相关的新型微小RNA特征的鉴定。
BMC Cancer. 2015 Feb 18;15:64. doi: 10.1186/s12885-015-1067-6.